Page 720 - 16Neonatal Jaundice_compressed
P. 720

Neonatal jaundice





              105.   Dawodu AH, Owa JA, and Familusi JB. A prospective study of the role of bacterial infection and G6PD deficiency in severe
                  neonatal jaundice in Nigeria. Tropical and Geographical Medicine 1984; 36:(2)127-32.
              106.   Manning D, Todd P, Maxwell M et al. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and
                  Ireland. Archives of Disease in Childhood Fetal and Neonatal Edition 2007; 92:(5)F342-F346.
              107.   Katar S, Akay HO, Taskesen M et al. Clinical and cranial magnetic resonance imaging (MRI) findings of 21 patients with serious
                  hyperbilirubinemia. Journal of Child Neurology 2008; 23:(4)415-7.
              108.   Tiker F, Gulcan H, Kilicdag H et al. Extreme hyperbilirubinemia in newborn infants. Clinical Pediatrics 2006; 45:(3)257-61.
              109.   Necheles TF, Rai US, and VALAES T. The role of haemolysis in neonatal hyperbilirubinaemia as reflected in carboxyhaemoglobin
                  levels. Acta Paediatrica Scandinavica 1976; 65:(3)361-7.
              110.   Bjerre  JV, Petersen JR, and Ebbesen F. Surveillance of extreme  hyperbilirubinaemia  in Denmark. A  method  to identify the
                  newborn infants. Acta Pædiatrica 2008; 97:1030-4.
              111.   Sgro M, Campbell D, and Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. Canadian Medical
                  Association Journal 2006; 175:(6)587-90.
              112.   Ogunlesi TA, Dedeke IO, Adekanmbi AF et al. The incidence and outcome of bilirubin encephalopathy in Nigeria: a bi-centre
                  study. Nigerian Journal of Medicine: Journal of the National Association of Resident Doctors of Nigeria 2007; 16:(4)354-9.
              113.   Maisels MJ and Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics 1995; 96:(4 Pt 1)730-3.
              114.   Hulzebos CV, van Imhoff DE, Bos AF et al. Usefulness of the bilirubin/albumin ratio for predicting bilirubin-induced neurotoxicity
                  in premature infants. [41 refs]. Archives of Disease in Childhood Fetal and Neonatal Edition 2008; 93:(5)F384-F388.
              115.   Malik  GK, Goel  GK, Vishwanathan PN  et al.  Free and erythrocyte-bound  bilirubin in neonatal jaundice.  Acta Paediatrica
                  Scandinavica 1986; 75:(4)545-9.
              116.   Chan G, Ilkiw R, and Schiff D. Clinical relevance of the plasma reserve albumin binding capacity for bilirubin (RABC) and "free"
                  bilirubin concentration. Clinical Biochemistry 1980; 13:(6)292-4.
              117.   de Carvalho WB, Kopelman BI, and de Araujo PS. Correlation between free bilirubin and indirect bilirubin in normal newborn
                  infants with non-hemolytic jaundice and effect of hemolysis on free bilirubin measurement by the peroxidase method. Revista
                  Paulista de Medicina 1992; 110:(3)138-44.
              118.   Newman TB, Hope S, and Stevenson DK. Direct bilirubin measurements in jaundiced term newborns. A reevaluation. American
                  Journal of Diseases of Children 1991; 145:(11)1305-9.
              119.   Newman TB, Easterling J, Goldman ES et al. Laboratory evaluation of jaundice in newborns. Frequency, cost, and yield. American
                  Journal of Diseases of Children 1990; 144:(3)364-8.
              120.   Unal S, Koc E, Aktas A et al. Prolonged jaundice in newborns: What is it actually due to? Gazi Medical Journal 2003; 14:(4)147-
                  51.
              121.   Tiker F, Tarcan A, Kilicdag H et al. Early onset conjugated hyperbilirubinemia in newborn infants. Indian Journal of Pediatrics
                  2006; 73:(5)409-12.
              122.   Hannam S, McDonnell M, and Rennie JM. Investigation of prolonged neonatal jaundice. Acta Paediatrica 2000; 89:(6)694-7.
              123.    Practice  parameter:  management  of  hyperbilirubinemia  in  the  healthy  term  newborn.  American  Academy  of  Pediatrics.
                  Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia.[Erratum appears in Pediatrics 1995
                  Mar;95(3):458-61]. Pediatrics 1994; 94:(4 Pt 1)558-65.
              124.   Burke BL, Robbins JM, Bird TM et al. Trends in Hospitalizations for Neonatal Jaundice and Kernicterus in the United States, 1988-
                  2005. Pediatrics 2009; 123:(2)524-32.
              125.   Barak M, Berger I, Dollberg S et al. When should phototherapy be stopped? A pilot study comparing two targets of serum bilirubin
                  concentration. Acta Paediatrica 2009; 98:(2)277-81.
              126.   Kaplan M, Kaplan E, Hammerman C  et al.  Post-phototherapy neonatal bilirubin rebound: a potential  cause of significant
                  hyperbilirubinaemia. Archives of Disease in Childhood 2006; 91:(1)31-4.
              127.    Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or
                  more weeks' gestation). [French, English]. Paediatrics and Child Health 2007; 12:(SUPPL. B)1b-24b.
              128.   Kaplan  M, Merlob  P,  and Regev  R. Israel guidelines  for  the  management of  neonatal  hyperbilirubinemia  and  prevention  of
                  kernicterus. Journal of Perinatology 2008; 28:(6)389-97.
              129.    National  Institute of Child  Health and Human Development randomized, controlled trials of phototherapy  for neonatal
                  hyperbilirubinemia. Pediatrics 1985; 75:(2 Pt 2)385-441.
              130.   Sisson TR, Kendall N, Glauser SC et al. Phototherapy of jaundice in newborn infant. I. ABO blood group incompatibility. Journal
                  of Pediatrics 1971; 79:(6)904-10.
              131.   Lewis HM, Campbell RH, and Hambleton G. Use or abuse of phototherapy for physiological jaundice of newborn infants. Lancet
                  1982; 2:(8295)408-10.
              132.   Meloni T, Costa S, Dore A et al. Phototherapy for neonatal hyperbilirubinemia in mature newborn infants with erythrocyte G-6-
                  PD deficiency. Journal of Pediatrics 1974; 85:(4)560-2.
              133.   Martinez JC, Maisels MJ, Otheguy L et al. Hyperbilirubinemia in the breast-fed newborn: A controlled trial of four interventions.
                  Pediatrics 1993; 91:(2)470-3.
              134.   Ju SH and Lin CH. The effect of moderate non-hemolytic jaundice and phototherapy on newborn behavior. Chung-Hua Min Kuo
                  Hsiao Erh Ko i Hsueh Hui Tsa Chih 1991; 32:(1)31-41.
              135.   Al-Alaiyan  S. Fiberoptic, conventional  and combination phototherapy for treatment of nonhemolytic hyperbilirubinemia  in
                  neonates. Annals of Saudi Medicine 1996; 16:(6)633-6.
              136.   Nuntnarumit  P  and  Naka  C.  Comparison  of  the  effectiveness  between  the  adapted-double  phototherapy  versus  conventional-
                  single phototherapy. Journal of the Medical Association of Thailand 2002; 85:(SUPPL. 4)S1159-S1166.
              137.   Boonyarittipong P, Kriangburapa W, and Booranavanich K. Effectiveness of double-surface intensive phototherapy versus single-
                  surface intensive phototherapy for neonatal hyperbilirubinemia. Journal of the Medical Association of Thailand 2008; 91:(1)50-5.
              138.   Tan KL. Efficacy of bidirectional fiber-optic phototherapy for neonatal hyperbilirubinemia. Pediatrics 1997; 99:(5)E13.
              139.   Sarici SU, Alpay F, Dundaroz MR et al. Fiberoptic phototherapy versus conventional daylight phototherapy for hyperbilirubinemia
                  of term newborns. Turkish Journal of Pediatrics 2001; 43:(4)280-5.
              140.   Gale R, Dranitzki Z, Dollberg S et al. A randomized, controlled application of the Wallaby phototherapy system compared with
                  standard phototherapy. Journal of Perinatology 1990; 10:(3)239-42.

              514
   715   716   717   718   719   720   721   722   723